Infanrix Hexa 40 Unit

Infanrix Hexa 40 Unit is a vaccine suspension designed for intramuscular administration. It combines multiple antigens to protect against serious diseases, including polio. This hexavalent vaccine is suitable for pediatric use and is manufactured by GlaxoSmithKline Inc.

Infanrix Hexa 40 Unit is used to vaccinate children against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and Haemophilus influenzae type b. This vaccine is typically administered as part of a routine immunization schedule to provide broad protection against these infectious diseases. Parents and healthcare providers often seek this vaccine to ensure comprehensive coverage for young children.

Common effects of Infanrix Hexa 40 Unit may include mild redness, swelling, or tenderness at the injection site. Some children may experience fever, irritability, or loss of appetite following vaccination. These effects are generally mild and temporary, resolving within a few days. Severe reactions are rare but should be reported to a healthcare professional immediately.

Infanrix Hexa 40 Unit should be stored and handled according to the manufacturer's guidelines to maintain its efficacy. It is important to inform healthcare providers about any allergies or previous adverse reactions to vaccines. This vaccine should not be administered to individuals with a history of severe allergic reactions to any of its components. Always follow the advice of a healthcare professional regarding vaccination schedules and precautions.

Infanrix Hexa 40 Unit may interact with other medications or vaccines. It is generally recommended to avoid administering this vaccine simultaneously with other live vaccines. Alcohol and certain medications may affect the immune response, so it is advisable to consult a healthcare provider before vaccination. Always disclose all current medications and health conditions to ensure safe administration.